Target intelligence / Profile preview

Long intergenic non-protein coding RNA 524 (LINC00524)

Target
LINC00524
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA, Other (non-coding RNA class)
01

Overview

Long intergenic non-protein coding RNA 524 (LINC00524) is a long non-coding RNA, meaning it does not encode a protein product but instead functions at the RNA level. It is overexpressed in multiple cancers, particularly breast cancer, where it promotes cell proliferation, migration, invasion, and metastasis. Mechanistically, it interacts with proteins such as TDP43 to stabilize their expression, which in turn promotes tumor progression. High levels of LINC00524 expression have been associated with poor prognosis in breast cancer. As a molecular entity, LINC00524 belongs to the family of long non-coding RNAs and is being investigated in preclinical settings as a potential biomarker and possible target for RNA-based therapeutic approaches, though no drugs currently target it directly[1][5].

02

Mechanism of action

no approved or experimental mechanism for drugs specifically targeting LINC00524; its function is mainly as a molecular scaffold or regulator via RNA-protein interactions, such as binding TDP43 in cancer

03

Biological functions

Regulation of gene expressionRibonucleoprotein complex biogenesisrRNA bindingRNA splicingCell proliferationCell migration and invasion
04

Disease associations

Cancer (notably Breast cancer, Oral squamous cell carcinoma, Renal clear cell carcinoma)Cancer metastasisPoor prognosis marker in several tumor types
05

Safety considerations

Not applicable to direct pharmacological targeting as no drugs are established; theoretical concerns would include off-target effects if targeted by nucleic acid-based therapeutics
06

Biomarkers

Potential prognostic biomarker for breast cancer and possibly other cancers, due to correlation with poor prognosis and metastasis

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 524 (LINC00524).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 524 (LINC00524).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call